Summary
The pharmacokinetic of azlocillin was followed in five elderly patients after biliary surgery. Total clearance was 138.6±17.7 ml/min when 2.0 g was given as an i.v. bolus injection. The half-life of the β-phase averaged 110 min. The total clearance and the half-life of azlocillin were influenced by slight impairment of renal function (creatinine clearance 59.4±13.6 ml/min). In patients with normal liver function biliary excretion of the drug amounted to 5.3±2.8% of the dose (n=3) and the kinetics of biliary excretion were linear. In contrast, in two patients with impaired liver function biliary excretion was 0.2% and 0.5% of the dose, and kinetic analysis of biliary excretion rates revealed at least one zero order step in the excretion process. Renal excretion of the drug amounted to 45.0±17.7% of the dose, which means that 50% of the total clearance of azlocillin has to be accounted for by metabolic clearance.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Bywater MJ, Holt HA, Broughall MJ, Reeves DS (1978) Azlocillin, Mezlocillin, Pivmecillinam, Mecillinam, and PC-904. Curr Chemother 35: 624–626
Chattopadhyay B, Hall I (1979) In vitro activity of azlocillin against Pseudomonas. Lancet 1: 391
Cockcroft DW, Gault MH (1976) Prediction of creatinine clearance from serum creatin creatinine. Nephron 16: 31–41
Davies DF, Shock NW (1950) Age dependent changes in glomerular filtration rate, effective renal plasma flow, and tubular excretory capacity in adult males. J Clin Invest 29: 496–507
Fu KP, Neu HC (1978) Azlocillin and Mezlocillin: new ureidopenicillins. Antimicrob Agents Chemother 13: 930–938
Gundert-Remy U, Förster D, Schacht P (1978) Pharmakokinetische Untersuchungen von Mezlocillin unter besonderer Berücksichtigung der Galleausscheidung. In Spitzy KH, Weuta H, Wiechert E (eds): Internationales Symposium Acylureido-Penicilline, Stuttgart. Verlag angewandte Wissenschaften, München, pp 137–143
Gundert-Remy U, de Vries JX (1979) Determinations of the ureidopenicillins Azlocillin, Mezlocillin and Bay k 4999 in plasma by high performance liquid chromatography. Br J Clin Pharmacol 8: 589–592
Gundert-Remy U (1979) Zur biliären Exkretion von Ureidopenicillinen. Habilitationsschrift, Heidelberg
Hattingberg HM von, Brockmeier D, Kreuter G (1976) A rotating iterative procedure (RIP) for estimating hybrid constants in multicompartment analysis on desk computer. Eur J Clin Pharmacol 11: 382–388
Keigley MRB, Drygsdale RB, Quoraishi AH, Burdon DW, Alexander-Williams J (1976) Antibiotics in biliary disease: The relative importance of antibiotic concentration in the bile and serum. Gut 17: 495–500
Lode H, Niestrath U, Koeppe P, Langmaak H (1977) Azlocillin and Mezlocillin: Zwei neue semisynthetische Acylureidopenicilline. Infection 5: 163–169
Siegel S (1956) Nonparametric statistics. Mc Graw Hill, New York, pp 116–127
Smith RL (1973) The excretory function of bile. John Wiley, New York, pp 16–33
Stewart D, Bodey GP (1977) Azlocillin: in vitro studies of a new semisynthetic penicillin. Antimicrob Agents Chemother 11: 865–870
Wirth K, Schomerus M, Hengstmann JH (1976) Zur Pharmakokinetic von Azlocillin, einem neuen halbsynthetischen Breitspektrumantibiotikum. Infection 4: 25–30
Wise R, Gillett AP, Andrews JM, Bedford KA (1978) Activity of azlocillin and mezlocillin against gram-negative organisms: Comparison with other penicillins. Antimicrob Agents Chemother 13: 559–565
Yastow J, Rosenthal A (1954) The excretion and concentration of terramycin in the abnormal human biliary tract. Ann Surg 139: 478–483
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Gundert-Remy, U., Weber, E. Elimination of azlocillin in patients with biliary t-tube drainage. Eur J Clin Pharmacol 22, 435–439 (1982). https://doi.org/10.1007/BF00542549
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00542549